A comprehensive view of Gerresheimer AG. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Gerresheimer Makes Solid Start to the Financial Year 2024
Published:
April 11, 2024
by Accesswire
|
Gerresheimer AG Reinvents Small Batch Glass Packaging, Sets Q1 2024 Financial Disclosure for Industry Stakeholders
Published:
April 04, 2024
by Industry Intelligence Inc.
|
Gerresheimer introduces three new performance levels for injection vials, syringes, cartridges and ampoules, the Gx Value, Gx Advance and Gx Elite; change expected to aid customers in choosing the appropriate products for their pharmaceutical requirements
Published:
April 03, 2024
by Gerresheimer AG
|
Gerresheimer AG Innovates With Smart Packaging Selector and Strengthens Industry Position at Combination Products Summit
Published:
April 02, 2024
by Industry Intelligence Inc.
|
Executive Perspective: Gerresheimer CEO predicts strong demand for weight-loss drugs to significantly boost the company's revenue growth; supply of vials, syringes, and other components for GLP-1 drugs expected to account for 4% of annual growth
Published:
April 01, 2024
by Invezz
|
Ask us about our Government & Public Policy market view